Cardiometabolic Care: Groundbreaking new HealthTech reality in 2025

Lloyd Price
3 minutes ago
4 min read

Cardiometabolic care is a comprehensive and integrated approach to managing the interconnected health conditions that affect both the cardiovascular system (heart and blood vessels) and the metabolic system (how the body processes food for energy).

Instead of treating these conditions in isolation, cardiometabolic care recognises their shared risk factors and aims to address them holistically to prevent serious complications like heart attack, stroke, type 2 diabetes, chronic kidney disease, and non-alcoholic fatty liver disease.

2025 is shaping up to be a groundbreaking period for HealthTech in cardiometabolic care. The focus is increasingly on proactive, personalised, and integrated solutions that leverage cutting-edge technologies to prevent, manage, and even reverse cardiometabolic conditions.

Here's a breakdown from the Nelson Advisors research team of the key HealthTech realities emerging in 2025:

1. AI and Machine Learning for Hyper-Personalisation

Predictive Analytics: AI is moving beyond simply analysing data to predicting individual risk profiles for conditions like type 2 diabetes, hypertension, and heart disease. This allows for earlier, targeted interventions.

Personalised Nutrition and Lifestyle Coaching: AI-driven platforms are providing highly tailored dietary recommendations (eg. personalised smoothie recipes based on health goals and sustainability) and exercise plans. These systems are becoming more sophisticated, even offering "virtual nutritionists" and leveraging large language models (LLMs) to make complex health information easily understandable.

Optimised Treatment Pathways: AI is being used to optimise personalised treatment plans, track progress, and provide educational resources, empowering individuals to self-manage their care while enhancing connections to their healthcare teams. Welldoc, for instance, is making strides in AI-powered digital coaching for various cardiometabolic conditions.

2. Advanced Remote Monitoring and Connected Devices

Continuous Glucose Monitoring (CGM) for All: The widespread adoption of CGMs, not just for people with diabetes but also for "curious consumers" wanting to monitor blood sugar responses, is a significant trend. Non-invasive CGMs are also on the horizon, promising greater accessibility and affordability.

Integrated Device Ecosystems: Connected devices like blood pressure monitors, smart scales, and wearables are seamlessly integrating with digital health platforms. Companies like Teladoc Health are building comprehensive cardiometabolic health programs that leverage patient-reported data and inputs from these connected devices to empower better outcomes.

"Hospital-at-Home" Models: Remote patient monitoring (RPM) is becoming a standard component of chronic disease care. IoT-powered virtual hospitals are scaling, offering cost-effective and personalized care, reducing hospital admissions, and improving quality of life for patients.

3. Genomics and Pharmacogenomics for Precision Care

Genomic Risk Assessment: Genomics is shifting the focus from treatment to prevention by identifying an individual's genetic predisposition to cardiometabolic conditions. This allows for proactive strategies to mitigate risk through lifestyle modifications and early interventions.

Tailored Medication (Pharmacogenomics): The understanding of how a person's DNA affects their response to drugs is leading to more precise prescribing. This means selecting the right medication and dosage for an individual, potentially reducing adverse reactions and improving treatment efficacy for conditions like cardiovascular disease.

4. Digital Therapeutics and Behavioral Change:

Evidence-Based Digital Interventions: Digital health solutions are increasingly being designed to drive healthy behaviours, addressing foundational pillars of cardiometabolic health such as diet, physical activity, sleep, and stress management.

Coordinated Care Models: Studies are demonstrating how anti-obesity medications (AOMs), such as GLP-1s, deliver significantly stronger outcomes when prescribed within structured, physician-led and digitally-supported care models. This emphasises the need for an "integrated clinical system" or "cardiometabolic home" that supports the patient throughout their journey.

5. Data-Driven Insights and Interoperability

Population Health Management: Aggregating vast amounts of population health data allows healthcare systems to identify at-risk individuals earlier, target interventions, and shift from reactive hospital care to proactive prevention.

Seamless Data Exchange: The push for integrated care systems is breaking down traditional silos, with digital solutions playing a central role in joining up services and ensuring data flows smoothly between different providers and patient-facing applications. Blockchain technology is also being explored for secure and tamper-proof storage of patient records.

While the advancements are significant, challenges remain, including ensuring digital equity (making sure these solutions are accessible and affordable for all populations), addressing data privacy and security, and fostering widespread adoption and adherence to these new technologies.Nevertheless, 2025 is solidifying the reality that HealthTech is not just an add-on but a fundamental driver of transformation in cardiometabolic care, moving towards a future where care is more preventative, personalised, and effective.

Nelson Advisors > Healthcare Technology M&A

Nelson Advisors specialise in mergers, acquisitions & partnerships for Digital Health, HealthTech, Health IT, Consumer HealthTech, Healthcare Cybersecurity, Healthcare AI companies based in the UK, Europe and North America. www.nelsonadvisors.co.uk

Nelson Advisors regularly publish Healthcare Technology thought leadership articles covering market insights, trends, analysis & predictions @ https://www.healthcare.digital

We share our views on the latest Healthcare Technology mergers, acquisitions & partnerships with insights, analysis and predictions in our LinkedIn Newsletter every week, subscribe today! https://lnkd.in/e5hTp_xb

Founders for Founders > We pride ourselves on our DNA as ‘HealthTech entrepreneurs advising HealthTech entrepreneurs.’ Nelson Advisors partner with entrepreneurs, boards and investors to maximise shareholder value and investment returns. www.nelsonadvisors.co.uk

#NelsonAdvisors #HealthTech #DigitalHealth #HealthIT #Cybersecurity #HealthcareAI #ConsumerHealthTech #Mergers #Acquisitions #Partnerships #Growth #Strategy #NHS #UK #Europe #USA #VentureCapital #PrivateEquity #Founders #BuySide #SellSide